Welcome to LookChem.com Sign In|Join Free
  • or
1(2H)-Quinolinecarboxamide, N-ethyl-3,4-dihydro- is a chemical compound with the molecular formula C12H14N2O. It is a derivative of quinoline, a heterocyclic aromatic organic compound with a benzene ring fused to a pyridine ring. This specific compound features a carboxamide group attached to the quinoline structure, with an N-ethyl substituent and a 3,4-dihydro functional group. It is an important intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly those with potential anti-inflammatory, analgesic, and antipyretic properties. The compound is also known for its potential applications in the development of new drugs targeting central nervous system disorders.

2637-26-5

Post Buying Request

2637-26-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2637-26-5 Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

This is the IUPAC name of the compound, which provides a systematic way to name organic compounds.

Explanation

This is an alternative name for the compound, which is often used in the pharmaceutical industry and research.
4. Quinolinecarboxamide Derivative

Explanation

The compound is derived from quinolinecarboxamide, which is a core structure in the molecule.
5. Pharmaceutical Industry Use

Explanation

It is commonly used in the pharmaceutical industry, indicating its potential applications in drug development.
6. Potential Medical Applications

Explanation

The compound may be used in the development of drugs for various medical conditions, although specific applications are not mentioned.
7. Industrial and Research Uses

Explanation

Apart from pharmaceutical applications, the compound may also have other uses in industry and research, although specific uses are not provided.
8. Safety and Handling

Explanation

It is important to handle and use the compound with appropriate care, following safety guidelines and regulations to ensure the safety of individuals and the environment.

Explanation

The appearance of the compound (e.g., color, state of matter) is not mentioned in the provided information.

Explanation

The solubility of the compound in various solvents is not provided in the material.

Explanation

Information about the stability of the compound under different conditions (e.g., temperature, light exposure) is not provided.

Explanation

The reactivity of the compound with other substances or under specific conditions is not mentioned in the material.

Check Digit Verification of cas no

The CAS Registry Mumber 2637-26-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,3 and 7 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2637-26:
(6*2)+(5*6)+(4*3)+(3*7)+(2*2)+(1*6)=85
85 % 10 = 5
So 2637-26-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H16N2O/c1-2-13-12(15)14-9-5-7-10-6-3-4-8-11(10)14/h3-4,6,8H,2,5,7,9H2,1H3,(H,13,15)

2637-26-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Ethyl-3,4-dihydro-1(2H)-quinolinecarboxamide

1.2 Other means of identification

Product number -
Other names 3,4-dihydro-2H-quinoline-1-carboxylic acid ethylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2637-26-5 SDS

2637-26-5Upstream product

2637-26-5Downstream Products

2637-26-5Relevant academic research and scientific papers

INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES

-

Page/Page column 33, (2012/02/01)

Disclosure is provided for carbamate compounds that prevent, remove and/or inhibit the formation of biofilms, compositions including these compounds, devices including these compounds, and methods of using the same.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2637-26-5